SCHEMBL30367341

SCHEMBL30367341

COCOc1ccc2c(Cl)c(C(C)C)c(C)nc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
KDM4E B2RXH2 3/20 0.32
GAA P10253 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MAPT P10636 2/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
PDE2A O00408 5/20 0.31
PDE10A Q9Y233 5/20 0.31
MAOA P21397 2/20 0.30
TSHR P16473 1/20 0.30
HBB P68871 1/20 0.30
HSD17B10 Q99714 1/20 0.30
DYRK1A Q13627 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28974954 1.00 MPO (0.34) MPONPSR1KDM4EGAAL3MBTL1
SCHEMBL23887808 0.85 MPO (0.47) MPONPSR1KDM4EGAAL3MBTL1
SCHEMBL23887697 0.78 DYRK1A (0.39) PDE10AMAOADYRK1A
SCHEMBL25544331 0.76 ALDH1A1 (0.39) NPSR1KDM4EMAPTKMT2AALDH1A1
SCHEMBL23887701 0.74 TRPV1 (0.37) MPOKDM4EGAAMAPTKMT2A
SCHEMBL30120959 0.74 TRPV1 (0.37) MPOKDM4EGAAMAPTKMT2A
SCHEMBL7125134 0.70 MAOA (0.53) MPOKDM4EMAPTALDH1A1HPGD
SCHEMBL23896011 0.69 MPO (0.47) MPONPSR1KDM4EGAAL3MBTL1
SCHEMBL28298305 0.65 FFAR1 (0.37) KDM4EL3MBTL1KMT2AMAOALMNA
SCHEMBL23832432 0.64 CYP2A6 (0.45) KDM4EMAPTMAPK1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697969-A 7-or 8-hydroxy-isoquinoline and 7-or 8-hydroxy-quinoline derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-02-03 CN disclosed